ADM Korea Inc
KOSDAQ:187660
ADM Korea Inc
Research & Development
ADM Korea Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Research & Development
-₩10.7B
|
CAGR 3-Years
-158%
|
CAGR 5-Years
-74%
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Research & Development
-₩173.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-176%
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Research & Development
-₩15.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-24%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Research & Development
-₩20.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Research & Development
-₩4.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Research & Development
-₩171.1B
|
CAGR 3-Years
-72%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-36%
|
|
ADM Korea Inc
Glance View
ADM Korea, Inc. engages in providing clinical operations. The company is headquartered in Seoul, Seoul. The company went IPO on 2021-06-03. The firm is a contract research organization (CRO) that provides clinical trial related services to pharmaceutical companies and bio ventures. The firm also provides post-marketing research (rPMS) services.
See Also
What is ADM Korea Inc's Research & Development?
Research & Development
-10.7B
KRW
Based on the financial report for Dec 31, 2024, ADM Korea Inc's Research & Development amounts to -10.7B KRW.
What is ADM Korea Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-74%
Over the last year, the Research & Development growth was -1 783%. The average annual Research & Development growth rates for ADM Korea Inc have been -158% over the past three years , -74% over the past five years .
